Chemotherapy treatment patterns and neutropenia management in gastric cancer.

Item

http://www.wikidata.org/entity/Q46057636

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

@en

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

@nl

type

Item

label

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

@en

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

@nl

prefLabel

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

@en

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

@nl

P1476

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

@en

P2093

Alain Hendlisz

http://www.w3.org/2001/XMLSchema#string

Florian D Vogl

http://www.w3.org/2001/XMLSchema#string

Javier Gallego Plazas

http://www.w3.org/2001/XMLSchema#string

Laurent Mineur

http://www.w3.org/2001/XMLSchema#string

Lucy DeCosta

http://www.w3.org/2001/XMLSchema#string

Rodolfo Passalacqua

http://www.w3.org/2001/XMLSchema#string

Tomas Salek

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy for advanced gastric cancer

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research.

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.

P2888

s10120-014-0375-x

P304

360-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10120-014-0375-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ewa Kalinka-Warzocha

P577

2014-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24792482

http://www.w3.org/2001/XMLSchema#string